M. S. Lukashenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
M. S. Lukashenko has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- O. V. Shcherbina
Shupyk National Healthcare University of Ukraine
1 shared publication - Pavlo Oleksandrovych Korol
Національний університет охорони здоров’я України імені П.Л. Шупика Міністерства охорони здоров’я України, Київ, Україна
1 shared publication - V. P. Ivchuk
Національний університет охорони здоров’я України імені П.Л. Шупика
1 shared publication - V. О. Murashko
Shupyk National University of Health of Ukraine, Kyiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 29 December 2023
- Published by Ukrainian Military Medical Academy in Ukrainian Journal of Military Medicine
- Vol. 4 (4) , 45-54
PET imagining in Alzheimer’s disease
Purpose. The purpose of this article is to explore the potential of positron emission tomography (PET) in early diagnosis of Alzheimer's disease (AD), monitoring of disease progression and assessment of treatment effectiveness. And also, to become familiar with advantages and disadvantages of application of various radiopharmaceuticals. Materials and methods. The material for the study was the scientific results of publications in professional scientific journals of the leading countries of the world of scientific and clinical activity over the past 10 years on the clinical significance of hybrid radiation imaging methods in the diagnosis and treatment of patients with AD. The study involved the use of PET radiation imaging methods in Alzheimer's disease. Results. The efficacy of PET at different stages of AD has been demonstrated. The advantages and disadvantages of using different PET techniques and different radiopharmaceuticals are discussed. PET, unlike other biomarkers, is able to assess the prevalence of lesions, evaluate progression and make a prediction of the further course of the disease. Conclusions. Positron emission tomography in patients with AD is an effective diagnostic technique that can be used at different stages from the prodromal period in the form of mild cognitive impairment to assessing the progression or effectiveness of treatment in numerous clinical trials.
- 29 December 2023
- Published by Ukrainian Military Medical Academy in Ukrainian Journal of Military Medicine
- Vol. 4 (4) , 45-54
Open AccessPET imagining in Alzheimer’s disease
Purpose. The purpose of this article is to explore the potential of positron emission tomography (PET) in early diagnosis of Alzheimer's disease (AD), monitoring of disease progression and assessment of treatment effectiveness. And also, to become familiar with advantages and disadvantages of application of various radiopharmaceuticals. Materials and methods. The material for the study was the scientific results of publications in professional scientific journals of the leading countries of the world of scientific and clinical activity over the past 10 years on the clinical significance of hybrid radiation imaging methods in the diagnosis and treatment of patients with AD. The study involved the use of PET radiation imaging methods in Alzheimer's disease. Results. The efficacy of PET at different stages of AD has been demonstrated. The advantages and disadvantages of using different PET techniques and different radiopharmaceuticals are discussed. PET, unlike other biomarkers, is able to assess the prevalence of lesions, evaluate progression and make a prediction of the further course of the disease. Conclusions. Positron emission tomography in patients with AD is an effective diagnostic technique that can be used at different stages from the prodromal period in the form of mild cognitive impairment to assessing the progression or effectiveness of treatment in numerous clinical trials.